Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever. The decline in early Tokyo ...
Deal for U.S. drugmaker Upsher-Smith Laboratories poised to boost sales for Sawai
For decades, the Sawai family was content to keep the drug business it founded focused on the Japanese market. Now, it is steering the country's second-biggest maker of generic drugs through its first overseas acquisition in its 88-year history. Sawai Pharmaceutical Co., which plans to ...
Pharma, aerospace industries seek Brexit assurances after Nissan deal
Britain's pharmaceutical and aerospace industries, both big exporters, are stepping up pressure on the government for assurances about their future after last week's post-Brexit deal with carmaker Nissan. The two sectors, which have been talking to ministers since the summer, are pressing their case after ...
Japan's Sosei sees more tie-ups with international drugmakers in the pipeline
Japan's Sosei Group Corp., which has seen its stock triple over the past year on tie-ups with international companies, could enter into more partnerships in 2016 to develop new medicines and diversify beyond its main lung disease treatment. There are drugs in the company's pipeline ...
Drugs of the future will be computer-designed
The moment Hideaki Fujitani unlocks the heavy door and enters the room, the buzzing noise — which sounded like a simple hum from the outside — gets much louder. "The noise is from the cooling fans," he shouts as he tries to tidy up his ...
With the relatively successful Super Cool Biz campaign over for the autumn, the next drive for saving energy is already under way. Warm Biz is the latest campaign to save energy after the March disasters in Tohoku left dozens of nuclear reactors offline and ...
